Cabozantinib,Nivolumab,Ipilimumab
Exelixis,bms
['bcsm']
#esmo22 wonderful to see most aspects discussed, when making treatment decisions. and we have to think hard, when we have no proof for prolonging os, when #tox / qol are worth it. in #bcsm, we learned: sequential vs combo same os for chemo mostly. 
Translational Medical Oncologist (Biomarkers, Toxicities, Health Outcomes, Clinico-Genomic Big Data) @OncoAlert. Motto: "Let's make a difference". Views mine.